Literature DB >> 8383219

Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles.

R C Rose1, W Bonnez, R C Reichman, R L Garcea.   

Abstract

The L1 coat protein of human papillomavirus type 11 (HPV-11) was expressed in Sf-9 insect cells with the recombinant baculovirus vector Ac11L1. Viruslike particles (VLPs) were identified by electron microscopy in the nucleus and cytoplasm of Sf-9 cells infected with Ac11L1. The L1 protein was purified from Ac11L1-infected insect cells. The purified protein spontaneously assembled in vitro into various aggregates, including particles appearing similar to empty virions. Reaction of VLP-containing insect cell extracts with antisera directed against either denatured or nondenatured capsid epitopes in Western blot (immunoblot) and immuno-dot blot assays suggested that conformational epitopes present in native HPV-11 infectious virions were also present on the baculovirus-produced HPV-11 VLPs. Immuno-dot blot assays using human sera obtained from individuals with biopsy-proven condyloma acuminatum correlated closely with results previously obtained in HPV-11 whole virus particle-based enzyme-linked immunosorbent assays. These morphologic and immunologic similarities to native HPV-11 virions suggest that recombinant VLPs produced in the baculovirus system may be useful in seroepidemiology and pathogenesis studies of genital HPV infection and that they may also be potential candidates for vaccine development.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8383219      PMCID: PMC240261     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  Polymorphism in the assembly of polyomavirus capsid protein VP1.

Authors:  D M Salunke; D L Caspar; R L Garcea
Journal:  Biophys J       Date:  1989-11       Impact factor: 4.033

2.  Use of human papillomavirus type 11 virions in an ELISA to detect specific antibodies in humans with condylomata acuminata.

Authors:  W Bonnez; C Da Rin; R C Rose; R C Reichman
Journal:  J Gen Virol       Date:  1991-06       Impact factor: 3.891

3.  A negative regulatory element in the human papillomavirus type 16 genome acts at the level of late mRNA stability.

Authors:  I M Kennedy; J K Haddow; J B Clements
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

4.  Analysis of human papillomavirus type 16 late mRNA 3' processing signals in vitro and in vivo.

Authors:  I M Kennedy; J K Haddow; J B Clements
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

5.  Humoral assays of human sera to disrupted and nondisrupted epitopes of human papillomavirus type 1.

Authors:  J C Steele; P H Gallimore
Journal:  Virology       Date:  1990-02       Impact factor: 3.616

6.  Expression in Escherichia coli of seven DNA fragments comprising the complete L1 and L2 open reading frames of human papillomavirus type 6b and localization of the 'common antigen' region.

Authors:  D G Strike; W Bonnez; R C Rose; R C Reichman
Journal:  J Gen Virol       Date:  1989-03       Impact factor: 3.891

7.  Monoclonal antibody-mediated neutralization of infectious human papillomavirus type 11.

Authors:  N D Christensen; J W Kreider; N M Cladel; S D Patrick; P A Welsh
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

8.  Expression of the full-length products of the human papillomavirus type 6b (HPV-6b) and HPV-11 L2 open reading frames by recombinant baculovirus, and antigenic comparisons with HPV-11 whole virus particles.

Authors:  R C Rose; W Bonnez; D G Strike; R C Reichman
Journal:  J Gen Virol       Date:  1990-11       Impact factor: 3.891

9.  Antibody-mediated neutralization in vivo of infectious papillomaviruses.

Authors:  N D Christensen; J W Kreider
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

10.  Synthesis of immunogenic, but non-infectious, poliovirus particles in insect cells by a baculovirus expression vector.

Authors:  T Urakawa; M Ferguson; P D Minor; J Cooper; M Sullivan; J W Almond; D H Bishop
Journal:  J Gen Virol       Date:  1989-06       Impact factor: 3.891

View more
  104 in total

1.  RNA is a structural element in retrovirus particles.

Authors:  D Muriaux; J Mirro; D Harvin; A Rein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

2.  DNA-induced structural changes in the papillomavirus capsid.

Authors:  C Fligge; F Schäfer; H C Selinka; C Sapp; M Sapp
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Optimization of a human papillomavirus-specific enzyme-linked immunosorbent assay.

Authors:  Kevin L Karem; Alysia C Poon; Cynthia Bierl; Rosane Nisenbaum; Elizabeth Unger
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

4.  Diffusion of macromolecules and virus-like particles in human cervical mucus.

Authors:  S S Olmsted; J L Padgett; A I Yudin; K J Whaley; T R Moench; R A Cone
Journal:  Biophys J       Date:  2001-10       Impact factor: 4.033

5.  Further evidence that papillomavirus capsids exist in two distinct conformations.

Authors:  Hans-Christoph Selinka; Tzenan Giroglou; Thorsten Nowak; Neil D Christensen; Martin Sapp
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

6.  Protection of rabbits against challenge with rabbit papillomaviruses by immunization with the N terminus of human papillomavirus type 16 minor capsid antigen L2.

Authors:  Ratish Gambhira; Subhashini Jagu; Balasubramanyam Karanam; Patti E Gravitt; Timothy D Culp; Neil D Christensen; Richard B S Roden
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

7.  Human papillomavirus-specific antibody status in oral fluids modestly reflects serum status in human immunodeficiency virus-positive individuals.

Authors:  Jennifer E Cameron; Isaac V Snowhite; Anil K Chaturvedi; Michael E Hagensee
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

8.  Detection of antibodies against human papillomavirus (HPV) type 16 virions by enzyme-linked immunosorbent assay using recombinant HPV 16 L1 capsids produced by recombinant baculovirus.

Authors:  P Le Cann; A Touze; N Enogat; D Leboulleux; C Mougin; M C Legrand; C Calvet; J M Afoutou; P Coursaget
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

9.  Polymer-based enzyme-linked immunosorbent assay using human papillomavirus type 16 (HPV16) virus-like particles detects HPV16 clade-specific serologic responses.

Authors:  Yevgeniy Y Studentsov; Gloria Y F Ho; Morgan A Marks; Robert Bierman; Robert D Burk
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

10.  Human papillomavirus type 11 recombinant L1 capsomeres induce virus-neutralizing antibodies.

Authors:  R C Rose; W I White; M Li; J A Suzich; C Lane; R L Garcea
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.